Huabo Kaisheng Dapoxetine Hydrochloride Tablets Obtained First Domestic Approval

Table 1: Drug BasicsSource: Company AnnouncementIt is learned that hydrochloric acid dapositinis is a short-acting selective 5-serotonin reuptake inhibitor (SSRIs), mainly applicable to the treatment of 18-64 year old male premature ejaculation patientsPremature ejaculation (PE) is a common male sexual dysfunction disorder, the incidence of high, the physical and mental health and quality of life of patients have a serious impactHydrochloric acid dapositinis is currently the only approved for the treatment of premature ejaculation of chemical drugs, but also domestic and foreign "premature ejaculation diagnosis and treatment guide" the first line of treatment drugs, its clinical benefits, and low safety risk, with rapid effect, rapid removal and low drug accumulation and other advantagesFigure 1: Sales of hydrochloric acid dapositine in key city public hospitals (unit: million yuan)source: Minet key city public hospital terminal competition pattern
announcement mentioned that hydrochloric acid daPositin tablets are now officially listed in many countries and regions, in 2010 approved for listing in ChinaThis hydrochloric acid dapositin tablets is the first in china in accordance with the chemical drug 4 categories of declaration, and in accordance with the original research quality consistency evaluation requirements approved by the same varieties, for the domestic first imitationUp to now, the company has invested about 7.597 million yuan in research and development projects in the hydrochloric acid Dapositin tablet sliverat present, in the trial of hydrochloric acid dapositin tablets 4 types of imitation acceptance number also involved in Colum Pharmaceuticals, Xinlitai, Yangzijiang and other 4 pharmaceutical enterprises, according to the CDE contractor time, the earliest declaration is Colum Pharmaceuticals, this time by Yantai Lu Yin Pharmaceuticals and Shandong Huaplatinum Kaisheng joint venture beyondsource: Mi net database, listed company announcementoriginal title: "attention" first imitation! The only approved PE drug was taken down by Guangdong listed pharmaceutical companies